Sunday, June 5 | 4:15 AM - 5:45 PM
William C. Lavely, MD, Vanderbilt University in Nashville, Tenn.; and
Pradeep G. Bhambhvani, MD, University of Alabama at Birmingham.
Studies to be presented are:
- Cost-effectiveness of FDG PET/CT in patients with Gram[+] bacteraemia;
- Remnant ablation success and differentiated thyroid carcinoma outcome in stage III/IV patients: Recombinant human thyrotropin vs. thyroid hormone withdrawal;
- The incidence of clinically important PET-negative CT-positive findings in a large clinical PET/CT practice;
- Ga-68 DOTATOC PET/CT and In-111-DTPA-Octreotide SPECT for staging of enteropancreatic neuroendocrine tumors: Evaluation of costs and consequential costs;
- Outpatient treatment of hyperthyroidism: How to protect the public?;
- Direct comparison of neck pinhole dual-tracer and dual-phase sestamibi accuracies with and without SPECT/CT for parathyroid adenoma localization; and
- Comparison of 2-deoxy-2-[F-18]fluoro-D-glucose uptake in the cerebellum and liver, reference organs for assessment of glucose metabolism, in oncologic patients.